ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Berberine inhibits gastric cancer progression by targeting canonical Wnt/β-catenin signaling in AGS cells.

Li Xiao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.